M R Jaff

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial
    Michael R Jaff
    The Vascular Center, Massachusetts General Hospital, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 80:343-50. 2012
  2. ncbi The Massachusetts General Hospital Vascular Center: emergence of a multidisciplinary program designed to improve quality outcomes for patients
    Michael R Jaff
    Massachusetts General Hospital, Boston, MA 02114, USA
    Hosp Pract (1995) 37:22-32. 2009
  3. ncbi Advances in the management of patients with vascular disease
    Michael R Jaff
    Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
    Expert Rev Cardiovasc Ther 10:151-3. 2012
  4. ncbi Turf wars: what certification brings to the public and the physician
    Michael R Jaff
    Division of Cardiovascular Medicine, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114, USA
    Am Heart Hosp J 3:277-8. 2005
  5. ncbi Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease
    Michael R Jaff
    Massachusetts General Hospital Vascular Center, 55 Fruit Street, GB 800, Boston, MA 02114, USA
    J Vasc Interv Radiol 21:1489-94. 2010
  6. ncbi Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis
    Ethan C Korngold
    Michael R Jaff, DO Section of Vascular Medicine, Division of Cardiovascular Medicine, Massachusetts General Hospital, 55 Fruit Street, Gray Bigelow 832, Boston, MA 02114, USA
    Curr Treat Options Cardiovasc Med 11:156-66. 2009
  7. ncbi High utilization rate of vena cava filters in deep vein thrombosis
    Michael R Jaff
    Massachusetts General Hospital, 55 Fruit Street, Yawkey Center for Outpatient Care, Room 5938, Boston, Massachusetts 02114, USA
    Thromb Haemost 93:1117-9. 2005
  8. ncbi Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Michael R Jaff
    Harvard Medical School, Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
    Catheter Cardiovasc Interv 74:S17-21. 2009
  9. ncbi Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVID
    Michael R Jaff
    Vascular Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Circulation 119:452-8. 2009
  10. ncbi Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography
    Michael R Jaff
    Section of Vascular Medicine, Division of Cardiovascular Medicine and the Division of Vascular Endovascular Surgery, The Massachusetts General Hospital Vascular Center, Boston 02114, USA
    Vasc Med 13:281-92. 2008

Detail Information

Publications53

  1. ncbi Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial
    Michael R Jaff
    The Vascular Center, Massachusetts General Hospital, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 80:343-50. 2012
    ..The HERCULES Trial is a prospective, multicenter trial of renal stenting in patients with uncontrolled HTN and ARAS evaluating the safety and effectiveness of the RX Herculink Elite Renal Stent System (Abbott Vascular, Santa Clara, CA)...
  2. ncbi The Massachusetts General Hospital Vascular Center: emergence of a multidisciplinary program designed to improve quality outcomes for patients
    Michael R Jaff
    Massachusetts General Hospital, Boston, MA 02114, USA
    Hosp Pract (1995) 37:22-32. 2009
    ....
  3. ncbi Advances in the management of patients with vascular disease
    Michael R Jaff
    Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
    Expert Rev Cardiovasc Ther 10:151-3. 2012
    ..This year, VIVA attracted some of the most important studies presented by international investigators. In this article details regarding new stent technologies in the aorta, peripheral artery and carotid arteries will be highlighted...
  4. ncbi Turf wars: what certification brings to the public and the physician
    Michael R Jaff
    Division of Cardiovascular Medicine, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114, USA
    Am Heart Hosp J 3:277-8. 2005
  5. ncbi Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease
    Michael R Jaff
    Massachusetts General Hospital Vascular Center, 55 Fruit Street, GB 800, Boston, MA 02114, USA
    J Vasc Interv Radiol 21:1489-94. 2010
    ....
  6. ncbi Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis
    Ethan C Korngold
    Michael R Jaff, DO Section of Vascular Medicine, Division of Cardiovascular Medicine, Massachusetts General Hospital, 55 Fruit Street, Gray Bigelow 832, Boston, MA 02114, USA
    Curr Treat Options Cardiovasc Med 11:156-66. 2009
    ....
  7. ncbi High utilization rate of vena cava filters in deep vein thrombosis
    Michael R Jaff
    Massachusetts General Hospital, 55 Fruit Street, Yawkey Center for Outpatient Care, Room 5938, Boston, Massachusetts 02114, USA
    Thromb Haemost 93:1117-9. 2005
    ..Many of these patients may have warranted less invasive methods of venous thromboembolism prophylaxis. Improved physician education regarding mechanical and pharmacologic prophylaxis alternatives might reduce the use of IVCFs...
  8. ncbi Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Michael R Jaff
    Harvard Medical School, Massachusetts General Hospital Vascular Center, 55 Fruit Street, Boston, MA 02114, USA
    Catheter Cardiovasc Interv 74:S17-21. 2009
    ....
  9. ncbi Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVID
    Michael R Jaff
    Vascular Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Circulation 119:452-8. 2009
    ..The objective of this phase-III trial was to assess the effect of a potent anti-Chlamydial agent, rifalazil, on peak walking time in patients with symptomatic peripheral artery disease...
  10. ncbi Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography
    Michael R Jaff
    Section of Vascular Medicine, Division of Cardiovascular Medicine and the Division of Vascular Endovascular Surgery, The Massachusetts General Hospital Vascular Center, Boston 02114, USA
    Vasc Med 13:281-92. 2008
    ..Physical examination is inaccurate in determining the presence and severity of carotid artery disease. Therefore, reliable imaging tests which offer little risk to the patient are required...
  11. ncbi Imaging the carotid bifurcation: toward standardization
    Michael R Jaff
    Harvard Medical School and Vascular Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Semin Vasc Surg 21:73-9. 2008
    ..This article will highlight the current strategies for carotid bifurcation imaging and will provide a diagnostic algorithm useful for centers involved in the management of carotid artery disease...
  12. ncbi The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study
    M R Jaff
    VasCore, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Catheter Cardiovasc Interv 68:684-9. 2006
    ..This is the report of the duplex ultrasound (DUS) substudy of the CLIP trial...
  13. ncbi Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease
    Michael R Jaff
    Massachusetts General Hospital Vascular Center, Boston, MA 02114, USA
    Ann Vasc Surg 24:577-87. 2010
    ..Despite the explosive advances in endovascular therapy, cost-effective methods of care have not been well defined. We analyze therapeutic strategies, outcomes, and medical cost of treatment among Medicare patients with PAD...
  14. ncbi Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"
    Thomas J Kiernan
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA
    Tech Vasc Interv Radiol 13:2-10. 2010
    ..This article reviews the comprehensive diagnostic algorithm and medical treatment strategies for patients with infrainguinal PAD...
  15. ncbi "The challenge facing renal artery revascularization: what have we not proven and why we must"?
    B G Hynes
    Section of Vascular Medicine, Division of Cardiology, Massachusetts General Hospital, Boston MA, USA
    Acta Chir Belg 110:575-83. 2010
    ..We must attempt to determine which patients are likely to benefit from renal artery stenting, assess the nuances of the percutaneous procedure and review the current literature pertaining to renal artery stenting...
  16. ncbi May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Stroke 40:1502-4. 2009
    ..We aimed to investigate the incidence of May-Thurner syndrome in patients with cryptogenic stroke with patent foramen ovale...
  17. ncbi Renal artery revascularization: collaborative approaches for specialists
    Thomas J Kiernan
    Department of Vascular Medicine and Intervention, Massachusetts General Hospital, Boston, MA 02114, USA
    Adv Chronic Kidney Dis 15:363-9. 2008
    ..Renal revascularization with a distal embolic protection device is a promising strategy in reducing the risk of atheroembolism and deterioration in kidney function...
  18. ncbi Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study
    Thomas J Kiernan
    Department of Medicine, Division of Cardiology, Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Vasc Med 14:233-7. 2009
    ..Unlike previous studies, LMCA or extent of CAD did not correlate with significant carotid artery disease. Using these predictive models, a prospective outcomes trial is required to validate these criteria...
  19. ncbi The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?
    Joshua A Beckman
    Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass, USA
    Circulation 114:861-6. 2006
    ..We encourage the USPSTF to reevaluate the extant data, add vascular specialty expertise to its review group, and reconsider its recommendation...
  20. ncbi Treatment strategies for peripheral artery disease
    Andrew B McCann
    Vascular Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Expert Opin Pharmacother 10:1571-86. 2009
    ..Endovascular techniques are commonly used in these patients. Combined pharmacological and endovascular strategies will play an increasing role in management of these patients in the future...
  21. ncbi Medical management of venous thromboembolic disease
    Steven Deitelzweig
    Ochsner Clinic Foundation, New Orleans, Louisiana, Section of Vascular Medicine, Lenox Hill Hospital, New York, NY, USA
    Tech Vasc Interv Radiol 7:63-7. 2004
    ..Emerging oral direct thrombin inhibitors and other novel agents stand to move the treatment of patients with venous thromboemboli to even greater levels of safety and efficacy...
  22. ncbi Treatment of renal artery in-stent restenosis with sirolimus-eluting stents
    Thomas J Kiernan
    Department of Interventional Cardiology and Vascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    Vasc Med 15:3-7. 2010
    ..05). In conclusion, placement of a SES for the treatment of ISR in renal arteries is associated with high initial technical success but significant restenosis on duplex ultrasonography at follow-up...
  23. ncbi Carotid duplex ultrasound velocity measurements versus intravascular ultrasound in detecting carotid in-stent restenosis
    Bryan P Yan
    Section of Vascular Medicine, Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
    Circ Cardiovasc Interv 2:438-43. 2009
    ..Duplex ultrasonography criteria for assessing the severity of carotid artery (CA) in-stent restenosis are not well established...
  24. ncbi External iliac artery endofibrosis in an amateur runner: hemodynamic, angiographic, histopathological evaluation and percutaneous revascularization
    Andrew O Maree
    Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Vasc Med 12:203-6. 2007
    ..The diagnosis was made by a combination of hemodynamic, angiographic and histopathological assessment and percutaneous revascularization was performed using a balloon expandable stent...
  25. ncbi Optimal risk factor modification and medical management of the patient with peripheral arterial disease
    Yung Wei Chi
    Department of Cardiology, Section of Vascular Medicine, Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
    Catheter Cardiovasc Interv 71:475-89. 2008
    ..This article reviews the current medical treatment and risk factor modification of patients with PAD...
  26. ncbi An 82-year-old woman with worsening hypertension: review of renal artery stenosis
    Kenneth Rosenfield
    Harvard Medical School, and Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, USA
    JAMA 300:2036-44. 2008
    ..The role of medical therapy, surgery, and endovascular therapy are reviewed, particularly in the context of guidelines and systematic reviews to help clinicians and patients facing this challenging decision...
  27. ncbi Postgraduate training in vascular medicine: proposed requirements and standards
    Mark A Creager
    Harvard Medical School, Boston, MA, USA
    Vasc Med 8:47-52. 2003
  28. ncbi Should all coronary angiographies be accompanied by a renal arteriogram (and stent)? The argument for
    Michael R Jaff
    Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA
    J Clin Hypertens (Greenwich) 6:513-5. 2004
  29. ncbi The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results
    Donald Ponec
    Department of Radiology, Tri City Medical Center, 4002 Vista Way, Oceanside, CA 92056, USA
    J Vasc Interv Radiol 15:911-8. 2004
    ....
  30. ncbi Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry
    John Laird
    Washington Hospital Center, Division of Cardiology, Indianapolis, IN, USA
    J Vasc Interv Radiol 16:1067-73. 2005
    ..The patency rate observed compares favorably to that previously documented with conventional angioplasty...
  31. ncbi Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial
    Stephan H Duda
    Center for Diagnostic Radiology and Minimally Invasive Therapy, The Jewish Hospital Berlin, Heinz Galinski Strasse 1, 13347 Berlin, Germany
    J Endovasc Ther 13:701-10. 2006
    ..To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents...
  32. ncbi Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging
    Jeffrey W Olin
    Circulation 109:2626-33. 2004
  33. ncbi Protected carotid stenting in high-risk patients with severe carotid artery stenosis
    Robert D Safian
    Cardiac and Vascular Intervention, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    J Am Coll Cardiol 47:2384-9. 2006
    ..The purpose of this study was to determine the safety of carotid artery stenting with a unique distal embolic protection system in high-risk patients with severe carotid stenosis...
  34. ncbi Lower extremity arterial disease. Diagnostic aspects
    Michael R Jaff
    Vascular Ultrasound Core Laboratory, Morristown, NJ, USA
    Cardiol Clin 20:491-500, v. 2002
    ....
  35. ncbi Pharmacotherapy for peripheral arterial disease: emerging therapeutic options
    Michael R Jaff
    The Vascular Ultrasound Core Laboratory, Morristown NJ 07960, USA
    Angiology 53:627-33. 2002
    ..Revascularization procedures, including nonsurgical and surgical techniques, can thus be reserved to improve patency and reduce the risk of limb loss in patients with PAD and IC with more severe impairment...
  36. ncbi Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease
    Krishna J Rocha-Singh
    Prairie Vascular Institute, Springfield, Illinois 62794 9420, USA
    Catheter Cardiovasc Interv 69:910-9. 2007
    ..This analysis proposes safety and performance goals for prospective single-arm trials of bare nitinol stents to treat patients with debilitating claudication associated with femoropopliteal (FP) atherosclerotic lesions...
  37. ncbi Diagnosis of peripheral arterial disease: utility of the vascular laboratory
    Michael R Jaff
    Vascular Diagnostic Laboratory, Heart and Vascular Institute, Morristown, New Jersey, USA
    Clin Cornerstone 4:16-25. 2002
    ..This article describes the basic noninvasive diagnostic tests, criteria for diagnosis, advantages and disadvantages of each diagnostic modality, and a strategy for PAD therapy...
  38. ncbi The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods
    Timothy P Murphy
    Rhode Island Hospital Vascular Disease Research Center and Brown Medical School Department of Diagnostic Imaging, Providence, RI 02903, USA
    J Vasc Surg 47:1356-63. 2008
    ....
  39. ncbi Protected carotid-artery stenting versus endarterectomy in high-risk patients
    Jay S Yadav
    Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    N Engl J Med 351:1493-501. 2004
    ..Stenting with the use of an emboli-protection device is a less invasive revascularization strategy than endarterectomy in carotid-artery disease...
  40. ncbi Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial
    Petr Svoboda
    Intensive Care, Traumatological Hospital, Masaryk University of Brno, Czech Republic
    Crit Care Med 32:1990-6. 2004
    ..The median +/- sd time to patency was 15 +/- 20.8 mins (range, 5-203 mins). CONCLUSION: The use of a new r-UK, 5000 IU/mL, is safe and effective for the restoration of patency to occluded CVADs...
  41. ncbi Vascular medicine in 2004: major steps toward national prominence
    Michael R Jaff
    Society for Vascular Medicine and Biology, Annual Scientific Sessions, Anaheim, CA, USA
    Vasc Med 9:135-7. 2004
  42. ncbi Medical treatment of peripheral arterial disease: a comprehensive review
    Athanasios Stoyioglou
    Department of Cardiology, Lenox Hill Hospital, New York, New York, USA
    J Vasc Interv Radiol 15:1197-207. 2004
    ..This article will review the clinical data supporting aggressive medical interventions for patients with PAD...
  43. ncbi Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventio
    Kenneth Rosenfield
    J Am Coll Cardiol 45:165-74. 2005
  44. ncbi The top 12 advances in vascular medicine
    Jeffrey W Olin
    Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Endovasc Ther 11:II21-31. 2004
    ....
  45. ncbi Where have we been? Where are we going?
    Michael R Jaff
    Society for Vascular Medicine and Biology, Chicago, Illinois, USA
    Vasc Med 10:231-3. 2005
  46. ncbi Surveillance imaging for carotid in-stent restenosis
    Corey K Goldman
    Division of Vascular Medicine, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
    Catheter Cardiovasc Interv 67:302-8. 2006
    ..We present three cases to illustrate the strengths and weaknesses of noninvasive imaging techniques for surveillance of carotid stents, ultimately validated with invasive contrast angiography...
  47. ncbi Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardi
    Christopher J White
    Circulation 114:1892-5. 2006
    ..This multispecialty consensus document describes the rationale for patient selection for screening renal angiography at the time of cardiac catheterization...
  48. ncbi Re: The American "board" of vascular medicine: questions and concerns
    Michael R Jaff
    J Vasc Interv Radiol 17:916-7; author reply 918. 2006
  49. ncbi Noninvasive diagnostic strategies for peripheral arterial disease
    Susan M Begelman
    Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA
    Cleve Clin J Med 73:S22-9. 2006
    ..Conventional angiography, the "gold standard" study for PAD diagnosis, is now usually pursued only once an intervention is planned...
  50. ncbi Carotid stent restenosis--a problem in search of a cure?
    Michael R Jaff
    Catheter Cardiovasc Interv 69:683-4. 2007
  51. ncbi Factors affecting long-term survival following renal artery stenting
    Mark C Bates
    Vascular Center of Excellence, Charleston Area Medical Center, Charleston, West Virginia, USA
    Catheter Cardiovasc Interv 69:1037-43. 2007
    ..This study defines clinical variables at the time of renal artery stenting that may be predictors of long-term all-cause mortality...
  52. ncbi The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications
    Christopher J White
    Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
    Catheter Cardiovasc Interv 71:721-5. 2008
    ..Finally, the CARE Registry satisfies the Center for Medicare and Medicaid Services (CMS) data reporting criteria for reimbursement...
  53. ncbi Renal artery stenosis: searching for the algorithms for diagnosis and treatment
    Zoltan G Turi
    J Am Coll Cardiol 41:1312-5. 2003